Risk Factors Update Summary
- The company sold an expanded interest in OMIDRIA royalties to DRI for $115.5 million.
- Royalty rate reduced from 50% to 30% in the U.S. and from 15% to 30% outside.
- The company may receive milestone payments of up to $27.5 million each in 2026 and 2028.
- The company's share repurchase program authorized up to $50.0 million, with $33.8 million remaining.
- The company had $213 million of 2023 Notes and $193 million of finance lease obligations outstanding.
- The company may face challenges managing growth, potentially exceeding anticipated costs.
- The company's business continuity and disaster recovery plans may not adequately protect from interruptions.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1285819&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.